Provident and Epharmix Use Mental Healthcare Technology to Save Lives Through Suicide Prevention
New partnership uses follow-up calls and automated texts to give patients
at risk for suicide better access to mental health services
St. Louis, MO — April 2017 — Provident, a mental healthcare organization with a 157-year history, is pleased to announce that they have formed a new partnership with innovative digital healthcare company Epharmix. The two organizations, both based in St. Louis, have teamed up to provide communication tools that give patients at risk for suicide more convenient access to mental health services while also improving care through follow-up phone calls and automated texts.
This is the first time the Epharmix technology has been used by an agency focused on suicide prevention.
“This partnership centers on one goal: saving lives. The digital tools created by Epharmix are a modern leap forward for our industry, equipping Provident’s care teams with a new way to identify at-risk patients and rapidly respond. We are constantly looking for opportunities to improve mental healthcare and couldn’t be more excited about the potential of this technology,” said Provident CEO Kevin Drollinger.
The Epharmix system uses automated texts and phone calls to collect patient-reported mental health status and share it with care teams in real time. Provident has implemented the technology as part of their Hope After program, which works to reduce the risk of suicide in adults following an attempt or crisis. Provident’s mental healthcare team is able to monitor a large and sensitive population between appointments and receive alerts, helping its care teams reach out to the right patient at the right time.
Patients are able to share their mental health status in a manner that is convenient while being reminded that there is a caring professional paying attention to their wellbeing. The result is better health outcomes for at-risk patients and a more streamlined workload for care teams.
“Epharmix is grateful and excited to help support the Provident team in bringing high-impact, innovative care to patients who need it most,” said Blake Marggraff, CEO of Epharmix. “The collaborative approach and technology-enabled team that Provident has designed are evidence that mental and behavioral health services can sustainably create brighter futures, and I’m proud that Epharmix is able to help.”
Serving the St. Louis Area since 1860, Provident is an accredited, nonprofit, United Way-funded agency that helps individuals and families to a brighter future through counseling, suicide prevention and intervention, and community support programs. They serve nearly 40,000 clients each year in the St. Louis region, throughout Missouri, and in all 50 states.
Provident’s Hope After program, which will implement the Epharmix technology, provides the Hope After suicide prevention services in partnership with Hyland Behavioral Health Center at St. Anthony’s Medical Center. Hope After is supported by a grant from U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA).
Epharmix builds communication tools to help care teams monitor the health of the most at risk patients. The text and phone-based system automatically collects biometrics and symptoms for 23 health conditions, from heart failure and diabetes to substance use and postpartum depression. Epharmix’s interventions are designed and piloted by 51 independent clinical researchers and 24 physicians across 10 academic institutions. Interventions align with a combined 42 quality metrics or national improvement initiatives, enabling revenue generation and cost savings in addition to greater staff efficiency.
Interactive Demo: Experience our communication tools from the perspective of both the patient and the care team: demo.epharmix.com
Video — https://vimeo.com/192490372
Press Kit — content.epharmix.com/epharmix-basic-kit.zip
Originally published at Epharmix.